Danimer Scientific Q4 2023 GAAP EPS $(0.39) Misses $(0.38) Estimate, Sales $10.900M Miss $11.333M Estimate
Portfolio Pulse from Benzinga Newsdesk
Danimer Scientific (DNMR) reported Q4 2023 GAAP EPS of $(0.39), missing the $(0.38) estimate, with sales of $10.900M also missing the $11.333M estimate. This represents a 28.87% decrease in sales compared to the same period last year.
March 28, 2024 | 8:02 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Danimer Scientific reported a Q4 2023 GAAP EPS of $(0.39), missing estimates, and sales of $10.900M, also below expectations. Year-over-year sales decreased by 28.87%.
Missing both EPS and sales estimates, especially with a significant year-over-year sales decrease, typically leads to negative investor sentiment in the short term. This could result in downward pressure on DNMR's stock price as the market reacts to the earnings miss and the significant decrease in sales compared to the previous year.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100